Effect of Cimetidine on the Transport of Quinolone Antibiotics in Caco-2 Cell monolayers |
Kim, Seon-Hwa
(Drug MetabolismTeam, Department of Pharmacology, National Institute of Toxicological Research)
Jung, Seo-Jeong (Center for Food & Drug Anaylsis, Busan KFDA) Um, So-Young (Drug MetabolismTeam, Department of Pharmacology, National Institute of Toxicological Research) Na, Mi-Ae (Testing & Analysis Team, Daejeon KFDA) Choi, Min-Jin (Drug MetabolismTeam, Department of Pharmacology, National Institute of Toxicological Research) Chung, Myeon-Woo (Drug MetabolismTeam, Department of Pharmacology, National Institute of Toxicological Research) Oh, Hye-Young (Drug MetabolismTeam, Department of Pharmacology, National Institute of Toxicological Research) |
1 | Guidance for Industry. Waiver of in vivo Bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a biopharmaceutics classification system. CDER, FDA, August, 2000 |
2 | Artursson P., Karlsson J. (1991) Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Commun. 175, pp. 880-885 DOI ScienceOn |
3 | Ayrton A., Morgan P. (2001) Role of transport proteins in drug absorption, distribution and excretion. Xenobiotica. 31, pp. 469-497 DOI |
4 | Chetan S. Karyekar, M.D., Ph.D., Natalie D. Eddington, Ph.D., Tushar S. Garimella, M.S., Paul O. Gubbins, Pharm.D., Thomas C. Dowling, Pharm.D., Ph.D. (2004) Evaluation of P-glycoprotein-Mediated Renal Drug Interactions in an MDR1-MDCK Model. Pharmacother. 23(4), pp. 436-442 DOI ScienceOn |
5 | Foote E.F. and Halstenson C.E. (1998) Effects of probenecid and cimetidine on renal disposition of ofloxacin in rats, Antimicrob. Agents Cehmother. 42, pp. 456-458 |
6 | Gan L.S., Hsyu P.H., Pritchard J.F., Thakker D. (1993) Mechanism of intestinal absorption of ranitidine and ondansetron: Transport across Caco-2 monolayers. Pharm. Res. 10, pp. 1722-1725 DOI |
7 | Hunter J., Jepson M.A., Tsuruo T., Simmons N.L., Hirst B.H. (1993) Functional expression of P-glycoprotein in apical membranes of human intestinal Caco-2 cells. Kinetics of vinblastine secretion and interaction with modulators. J. Biol. Chem. 268, pp. 14991-14997 |
8 | Jaehde U., Sorgel F., Stephan U., Schunack W. (1994) Effect of an antacid containing magnesium and aluminum on absorption, metabolism, and mechanism of renal elimination of pefloxacin in humans. Antimicrob. Agents Cehmother. 38, pp. 1129-1133 DOI ScienceOn |
9 | Juliano RL, Ling V. (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta. 455, pp. 152-162 DOI ScienceOn |
10 | Jung S.J., Choi S.O., Um S.Y., Kim J.I., Choo H.Y., Choi S.Y., Chung S.Y. (2006) Prediction of the permeability of drugs through study on quantitative structure-permeability relationship. J. Pharm. Biomed. Anal. 41, pp. 469-475 DOI ScienceOn |
11 | Kartner N., Riodan J.R., Ling V. (1983) Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science 221, pp. 1285-1288 DOI |
12 | Balayssac D., Authier N, Cayre A. Coudore F. (2005) Does inhibition of P-glycoprotein lead to drug-drug interactions? Toxicol Lett. 156, pp. 319-329 DOI ScienceOn |
13 | Behrens I., Kissel T. (2003) Do cell culture conditions influence the carrier-mediated transport of peptides in Caco-2 cell monolayers? Eur J Pharm Sci. 19, pp. 433-442 DOI ScienceOn |
14 | Gottesman, M.M., Pastan I. (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62, pp. 385-427 DOI ScienceOn |
15 | Collett A., Higgs N. B., Sims E., Rowland M., Warhurst G. (1998) Modulation of the permeability of H2 receptor antagonists cimetidine and ranitidine by P-glycoprotein in rat intestine and the human colone cell line Caco-2. J. Pharmacol. Exp. Ther., 288, pp. 171-178 |
16 | Geisen P., McColm J.R., King B.M., Hartnett M.E. (2006) Characterization of barrier properties and inducible VEGF expression of several types of retinal pigment epithelium in mediumterm culture. Curr Eye Res. 31, pp. 739-748 DOI ScienceOn |
17 | Germann U.A., Pastan I., Gottesman M.M. (1993) P-glycoproteins: Mediators of multidrug resistance. Semin. Cell Bil. 4, pp. 63-76 DOI ScienceOn |
18 | Hosoya K.I., Kim K.J., Lee V.H. (1996) Age-dependent expression of P-glycoprotein gp170 in Caco-2 cell monolayers. Pharm. Res. 13, pp. 885-890 DOI |
19 | Karyekar C.S., Eddington N.D., Briglia A., Gubbins P.O., Dowling T.C. (2004) Renal interaction between itraconazole and cimetidine. J. Clin. Pharmacol. 44, pp. 919-927 DOI |
20 | Klingberg T.D, Pedersen M.H., Cencic A., Budde B.B. (2005) Application of measurements of transepithelial electrical resistance of intestinal epithelial cell monolayers to evaluate probiotic activity. Appl Environ Microbiol. 71, pp. 7528-7530 DOI ScienceOn |
21 | Kolawole J.A., Mustapha A., Abudu-Aguye I., Ochekpe N. (2000) Mefloquine pharmacokinetics in healthy subjects and in peptic ulcer patients after cimetidine administration. Eur J Drug Metab Pharmacokinet. 25, pp. 165-170 DOI ScienceOn |
22 | Neu H.C. (1992) Quinolone antimicrobial agents. Annu. Rev. Med. 43, pp. 465-486 DOI ScienceOn |
23 | Kosoglou T., Salfi M., Lim J.M., Batra V.K., Cayen M.N., Affrime M.B. (2000) Evaluation of the pharmacokinetics and electrocardiographic pharmacodynamics of loratadine with concomitant administration of ketoconazole or cimetidine. Br J Clin Pharmacol. 50, pp. 581-589 DOI |
24 | Lazzaroni M, Imbimbo B.P., Bargiggia S., Sangaletti O., Dal Bo L., Broccali G., Bianchi Porro G.. (1993) Effects of magnesium-aluminum hydroxide antacid on absorption of rufloxacin. Antimicrob. Agents Chemother. 37, pp. 2212-2216 DOI ScienceOn |
25 | Narumi S., Kumiko T., Akihiro M., Kenji A., Hiroshi T., Koji F. (2006) Effect of benzo[a]pyrene on P-glycoprotein-mediated transport in Caco-2 cell monolayer. Toxicology 23, pp. 156-165 |
26 | Rubas W., Jezuk N., Grass G.M. (1993) Comparison of the permeability characteristics of a human colonic epithelial (Caco-2) cell line to colon of rabbit, monkey, and dog intestine and human drug absorption. Pharm. Res. 10, pp.113-118 DOI |
27 | Schinked, A.H., Mayer U., Wagenaar E., Mol C.A., van Deemter L. Smit J.J, van der Valk M.A., Voordouw A.C., Spits H., van Tellingen O., Zijlmans J.M., Fibbe W.E., Borst P. (1997) Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. Proc. Nat., Acad. Sci. 94, pp. 4028-4033 DOI ScienceOn |
28 | Shimada J., Shiba K., Oguma T., Miwa H., Yoshimura Y., Nishikawa T., Okabayashi Y., Kitagawa T., Yamamoto S. (1992) Effect of antacid on absorption of the quinolone lomefloxacin. Antamicrob. Agents Chemother. 36, pp. 1219-1224 DOI ScienceOn |
29 | Weidekamm E., Portmann R., Suter K., Partos C., Dell D., Lucker P.W. (1987) Single- and multiple-dose pharmacokinetics of fleroxacin, a trifluorinate quinolone, in humans. Antimicrob. Agents Chemother. 31, pp. 1909-1914 DOI ScienceOn |
30 | Suzuki H., Sugiyama Y. (2000) Role of metabolic enzymes and efflux transporters in the absorption of drugs from the small intestine. Eur J Pharm Sci. 12, pp. 3-12 DOI ScienceOn |
31 | Wise R. (1984) Norfloxacin, a review of pharmacology and tissue penetration. J. Antimicrobiol. Chemother. 13, pp. 59-64 |
32 | Pan B.H., Dutt A., Nelson A. (1994) Enhanced transepithelial flux of cimetidine by Madin-Darby Canine Kidney cells overexpressing human P-glycoprotein. J. Pharmacol. Exp. Ther., 270, pp. 1-7 |
33 | Pedersen K.E., Chrstiansen B.D., Klitgaard N.A., Nielsen-Kudsk, F. (1983) Effect of quinidine on dioxin bioavailability. Eur. J. Clin. Pharmacol. 24, pp. 41-47 DOI |